Top news of the week: 14.07.2021.
Startups
Prime Medicine Launches with $315 Million Financing to Deliver on the Promise of Prime Editing
/PRNewswire/ -- Prime Medicine™, a company delivering on the promise of Prime Editing to provide lifelong cures to patients, today announced its launch with...
This Gene Editing Startup Raised $315 Million For A Next Generation Crispr Tool To Cure Rare Diseases
Prime Medicine’s ‘search and replace’ platform could potentially correct up to 89% of the known mutations that can cause genetic disease.
J&J, Vor ally to assess bispecific and stem cell therapy in AML
Johnson & Johnson has teamed up with Vor Biopharma to study one of its bispecific antibodies in combination with technology designed to improve tolerability.
Atlas Venture Welcomes Jodie Morrison as Venture Partner
Jodie Morrison joins Atlas Venture as venture partner to build transformative biotech companies.
Biogen chases rivals with another bet on emerging class of multiple sclerosis drugs
A deal with Innocare gives Biogen a second therapy for MS that targets a protein called BTK, an approach several other competing drugmakers are pursuing, too.
Axios Pro Rata
— Felix Salmon, Axios • Clearco, a San Francisco-based provider of non-dilutive, revenue-based financing to startups, raised $215 million in new Series C funding from SoftBank …
Massachusetts Life Sciences Center funding to support a Metabolomics Facility at Dana-Farber
The Massachusetts Life Sciences Center is awarding Dana-Farber Cancer Institute a $1.82 million grant titled, Mass Spectrometry Metabolomics Solutions for Highly Scalable Integrated OMics: ...
Novo Nordisk puts $1.2B on the table for Prothena’s ATTR drug, teeing up Alnylam challenge and cardiovascular expansion
Novo Nordisk has struck a $1.2 billion deal to buy Prothena’s ATTR amyloidosis program. The deal will see Novo pay $100 million in upfront and near-term fees for worldwide rights to the ...